Journal
BONE MARROW TRANSPLANTATION
Volume 32, Issue 1, Pages 103-106Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bmt.1704070
Keywords
neuroblastoma; CD34; graft-versus-tumor
Categories
Ask authors/readers for more resources
A 5-year-old boy received CD34-positive HLA haplo-identical bone marrow transplantation from his father as treatment for refractory advanced neuroblastoma. He had residual disease in the para-aortic lymph nodes and multiple bones after the transplant. However, all of his residual disease had disappeared completely 3 years later. He developed grade I acute graft-versus-host disease (GVHD) but had no symptoms of chronic GVHD or any other complications. This case demonstrates the possibility of a graft-versus-tumor effect against neuroblastoma by HLA-mismatched allogeneic hematopoietic stem cell transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available